Kapelfarma SRL
2.6 FTEThe score of Kapelfarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +15 % Total assets +17 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kapelfarma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 120,309 € | ||||
| Equity | 182,062 € | ||||
| Cash | 82,912 € | ||||
| EBITDA | 213,124 € | ||||
| Total assets | 653,987 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 20 Aug 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
Kapelfarma's financial analysis
- Solvency27.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kapelfarma
Kapelfarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0872.471.745
- VAT number
- BE0872471745
- Peppol
- Registered · 0208:0872471745 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Mar 2005
- Registered office
- 2550 Kontich
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Kapelfarma (SRL) has been based in Kontich since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 120,309 € and equity of 182,062 €; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 27.8%, below the median of its sector (44.2%).
Companies similar to Kapelfarma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Oppuurs Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet 658,826 €
- Geassocieerde Apotheek Merksem Retail sale of pharmaceutical products Antwerp · balance sheet 623,918 €
- ViOph.arma Retail sale of pharmaceutical products Frameries · balance sheet 689,435 €
- Smith Pharma Retail sale of pharmaceutical products Willebroek · balance sheet 610,521 €
- Vermunicht Retail sale of pharmaceutical products Hulshout · balance sheet 602,591 €
- Pharmacie DE LA Jonction Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 601,403 €
- "Farminco" Retail sale of pharmaceutical products Andenne · balance sheet 589,804 €
- LS Pharma Retail sale of pharmaceutical products Gembloux · balance sheet 749,318 €
Frequently asked questions about Kapelfarma
What is the revenue of Kapelfarma?
Kapelfarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kapelfarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0872471745 for Kapelfarma, if the company is VAT-registered. Its company number (CBE) is 0872.471.745.
Where is the registered office of Kapelfarma?
According to the CBE register, the registered office of Kapelfarma is in 2550 Kontich.
What is the equity of Kapelfarma?
At the close of the 2025 financial year, the equity of Kapelfarma amounts to 182,062 €, a solvency of 27.8% of total assets.
How many people work at Kapelfarma?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Kapelfarma?
The register lists 5 active mandates at Kapelfarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kapelfarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →